An additional analysis of 43 published studies (5758 cases and 14,741 controls) showed that the homozygous mutation for HFE C282Y was substantially linked to a higher risk of HCC in comparison to the general population [127]. The gene discussed is HFE; the disease is hepatocellular carcinoma.